Pet Financial News
New Data on POSLUMA® (Flotufolastat F 18) in Patients with Suspected Biochemical Recurrence of Prostate Cancer and Low-Very Low Prostate Specific Antigen (PSA) Levels...
− Post-hoc evaluation from Blue Earth Diagnostics’ Phase 3 SPOTLIGHT trial offers information about therapy planning, significantly when healing salvage remedy is taken into...
Pet Financial News
Blue Earth Diagnostics Announces Additional Results from Phase 3 SPOTLIGHT Trial of Investigational FAMILY PET Imaging Agent 18F-rhPSMA-7.3 in Biochemical Recurrence of Prostate Cancer
− Results at the American Urological Association’s 2023 Annual Meeting (AUA2023) –MONROE AREA, N.J. & OXFORD, England, April 29, 2023--(BUSINESS WIRE)--Blue Earth Diagnostics,...
-Advertisement-
Must read
-Advertisement-